Clinical feature and ATP8B1 mutation analysis of a patient with progressive familial intrahepatic cholestasis type I.
- Author:
Ying CHENG
1
;
Li GUO
;
Yuan-Zong SONG
Author Information
1. Department of Pediatrics, First Affiliated Hospital, Jinan University, Guangzhou 510632, China. songyuanzong@vip.tom.com.
- Publication Type:Case Reports
- MeSH:
Adenosine Triphosphatases;
genetics;
Cholestasis, Intrahepatic;
genetics;
DNA Mutational Analysis;
Humans;
Infant;
Male;
Mutation;
Sequence Analysis, DNA
- From:
Chinese Journal of Contemporary Pediatrics
2016;18(8):751-756
- CountryChina
- Language:Chinese
-
Abstract:
Progressive familial intrahepatic cholestasis type I (PFIC1) is an autosomal recessive disorder caused by biallelic mutations of ATP8B1 gene, with progressive cholestasis as the main clinical manifestation. This paper reports the clinical and genetic features of a PFIC1 patient definitely diagnosed by ATP8B1 genetic analysis. The patient, a boy aged 14 months, was referred to the hospital with the complaint of jaundiced skin and sclera over 10 months. The patient had been managed in different hospitals, but the therapeutic effects were unsatisfactory due to undetermined etiology. On physical examination, hepatosplenomegaly was discovered in addition to jaundice of the skin and sclera. The liver was palpable 4 cm below the right subcostal margin and 2 cm below the xiphoid while the spleen 2 cm below the left subcostal margin. The liver function test revealed elevated levels of serum total bile acids, bilirubin, and transaminases; however, the γ-glutamyl transferase level was normal. The diagnosis was genetic cholestasis of undetermined origin. At the age of 1 year and 8 months, a Roux-en-Y cholecystocolonic bypass operation was performed, and thereafter the jaundice disappeared. At 5 years and 1 month, via whole genome sequencing analysis and Sanger sequencing confirmation, the boy was found to be a homozygote of mutation c.2081T>A(p.I694N) of ATP8B1 gene, and thus PFIC1 was definitely diagnosed. The boy was followed up until he was 6 years, and jaundice did not recur, but the long-term outcome remains to be observed.
